CTY Insider Trading Activity and SEC Form 4 Filings
CTY insider trading summary
Over the past 12 months, insiders at City Therapeutics, Inc. (CTY) reported 7 open-market purchases worth $21.4M by 7 insiders and no sales on SEC Form 4. Net insider buying was $21.4M.
Latest CTY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Robert Nelsen | Director | Buy | $3.1M (170,000 @ $18.00) |
| Oct 19, 2026 | ARCH Venture Partners XII, LLC | 10% Owner | Buy | $3.1M (170,000 @ $18.00) |
| Oct 19, 2026 | ARCH Venture Partners XII, L.P. | 10% Owner | Buy | $3.1M (170,000 @ $18.00) |
| Oct 19, 2026 | ARCH Venture Fund XII, L.P. | 10% Owner | Buy | $3.1M (170,000 @ $18.00) |
| Oct 19, 2026 | Keith Crandell | 10% Owner | Buy | $3.1M (170,000 @ $18.00) |
| Oct 19, 2026 | Kristina Burow | 10% Owner | Buy | $3.1M (170,000 @ $18.00) |
| Oct 19, 2026 | Steven Gillis | 10% Owner | Buy | $3.1M (170,000 @ $18.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.